Comparison of Permeation through Phosphatidylcholine Bilayers ofN-Dipicolinyl-α- and -β-Oligopeptides
- 21 November 2006
- journal article
- research article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 3 (11) , 1181-1201
Abstract
Cell-membrane permeation of small therapeutic peptides and peptidomimetics is a fundamental issue in pharmaceutical research. Using a Tb3+-based permeation assay, we have examined the ability of α- and β-peptides, bearing proteinogenic side chains and an N-terminal dipicolinic acid (DPA) monoamide group, to enter liposomes composed of egg phosphatidylcholine bilayers. A series of 12 DPA–peptides of increasing chain length was prepared and characterized by CD and NMR analysis. An interesting destabilizing effect of the N-terminal DPA group on the helical structure of a β-hexapeptide was discovered. Significant differences in permeation were observed between the DPA-α- and the DPA-β-peptides, with all β-peptidic compounds permeating better than their α-analogs. Thus, β-peptides have been shown to interact with lipid bilayers in a manner that is distinctly different from that of α-peptides. Together with the fact that β-peptides are proteolytically stable in mammalian organisms, and that they fold to form helices and hairpin turns with short chain lengths, the new results further emphasize the biomedical potential of β-peptides.Keywords
This publication has 45 references indexed in Scilit:
- A Novel apoE-Derived Therapeutic Reduces Vasospasm and Improves Outcome in a Murine Model of Subarachnoid HemorrhageNeurocritical Care, 2006
- Helices and other secondary structures of β‐ and γ‐peptidesPeptide Science, 2005
- Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic–ischemic injuryNeuroscience Letters, 2005
- Design and Structure of Peptide and Peptidomimetic Antagonists of Protein- Protein InteractionCurrent Protein & Peptide Science, 2005
- Design, Synthesis and Preclinical Evaluation of Radiolabeled Peptides for Diagnosis and TherapyCurrent Pharmaceutical Design, 2004
- The World of β‐ and γ‐Peptides Comprised of Homologated Proteinogenic Amino Acids and Other ComponentsChemistry & Biodiversity, 2004
- How we drifted into peptide chemistry and where we have arrived atTetrahedron, 2004
- Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognitionBreast Cancer Research, 2001
- β-Peptides: From Structure to FunctionChemical Reviews, 2001
- The Outstanding Biological Stability ofβ- andγ-Peptides toward Proteolytic Enzymes: An In Vitro Investigation with Fifteen PeptidasesChemBioChem, 2001